Target intelligence / Profile preview

Rab escort protein 1 (CHM) (REP1)

Target
REP1
Molecular classification
Rab escort protein, Protein prenylation factor, Enzyme cofactor
01

Overview

Rab escort protein 1 (REP1), encoded by the CHM gene, is a critical component of the Rab geranylgeranyltransferase (GGTase) complex essential for the post-translational modification of Rab GTPases (UniProt P24386). Its primary biological function is to bind newly synthesized Rab proteins and present them to the catalytic subunit of Rab GGTase for prenylation, a lipid modification necessary for membrane anchoring and the regulation of intracellular trafficking (NCBI Gene ID: 1121). In humans, a deficiency in REP1 leads to Choroideremia, a rare X-linked recessive retinal degeneration characterized by the progressive loss of the choroid, retinal pigment epithelium, and photoreceptors (MacLaren et al., 2014). While a closely related isoform, REP2, can compensate for REP1 in most tissues, it is insufficient in the retina, leading to the tissue-specific disease phenotype. Therapeutic strategies for this target focus on gene replacement therapy, utilizing adeno-associated virus (AAV) vectors to deliver a functional copy of the CHM gene to the subretinal space (Dimopoulos et al., 2018). These treatments aim to restore prenylation activity and halt the progression of vision loss in affected patients.

Other names
CHMChoroideremia proteinRab proteins geranylgeranyltransferase component ADXS540TCDGGTA
02

Mechanism of action

Gene replacement therapy via adeno-associated virus (AAV) vector delivery of a functional CHM gene to restore Rab escort protein 1 activity and Rab prenylation.

03

Biological functions

Protein prenylationIntracellular membrane traffickingVesicular transportRab geranylgeranylationProtein lipid modification
04

Disease associations

ChoroideremiaRetinal degenerationBlindness
05

Safety considerations

Retinal detachmentIntraocular inflammation (uveitis)Subretinal hemorrhageImmune response to viral vector
06

Interacting drugs

Timrepigene emparvovec (BIIB111)

1 more in the full profile.

07

Biomarkers

CHM gene mutationFundus autofluorescence (FAF) areaOptical coherence tomography (OCT) ellipsoid zone widthBest-corrected visual acuity (BCVA)

Beyond the preview

Go deeper on Rab escort protein 1 (CHM) (REP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab escort protein 1 (CHM) (REP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call